60 Mg Cabazitaxel Injection

Name: 60 Mg Cabazitaxel Injection
Brand: NEETCO BIOPHARMA
Price: 5500 INR
Availability: InStock

Price 5500 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

60 Mg Cabazitaxel Injection Specification

Indication
Treatment of metastatic castration-resistant prostate cancer

Dosage Form
Injection

Salt Composition
Cabazitaxel 60 mg

Enzyme Types
Non-enzyme based

Feature
Sterile, single-use vial

Ingredients
Cabazitaxel, polysorbate 80, ethanol, water for injection

Application
Antineoplastic agent

Ph Level
Neutral (approx. 7.0)

Physical Color/Texture
Clear to pale yellow solution

Fermentation Smell
Odorless

Storage Instructions
Store below 25C, protect from light

Shelf Life
24 months

Container Type
Glass vial with rubber stopper and aluminum seal

Ready to Use
Requires dilution before administration

Route of Administration
Intravenous infusion only

Registration Status
Registered pharmaceutical product

Manufacturer/Brand
Available from certified pharmaceutical manufacturers

Pack Size
1 vial of 1.5 ml for reconstitution

USP Standard
Conforms to IP/USP specifications

Hazard Precaution
Cytotoxic agenthandle with care

Prescription Category
Prescription Only Medicine

Contraindications
Known hypersensitivity to Cabazitaxel or excipients, neutropenia

Precautions
Use with caution in renal/hepatic impaired patients

About 60 Mg Cabazitaxel Injection

Reserve the unassailable potency of 60 Mg Cabazitaxel Injection, a commanding solution for metastatic castration-resistant prostate cancer. Strictly conforming to USP/IP standards, each affordable single-use vial ensures optimal therapeutic value. Ready to use after marked dilution, this cytotoxic antineoplastic agent is supplied by certified pharmaceutical manufacturers. Packaged in a sterile glass vial, its neutral pH and clear to pale yellow appearance affirm its quality. Prescription-only, this injection is reserved for intravenous infusion, offering unyielding efficacy where others may falter-remarked as an industry benchmark in India's pharmaceutical market.

Recommended Application and Material Feature

60 Mg Cabazitaxel Injection is designed exclusively for intravenous infusion in healthcare settings. Utilized in oncology for treating metastatic castration-resistant prostate cancer, its sterile glass vial allows single-use administration, maintaining uncompromised safety standards. The material feature includes a neutral pH and clear to pale yellow solution composed of Cabazitaxel, and essential excipients like polysorbate 80 and ethanol, ensuring reliable reconstitution and delivery to patients. Reserved for prescription, this non-enzyme based formulation meets strict clinical demands.

Market Availability and Pricing Details

The arrival of 60 Mg Cabazitaxel Injection in India's pharmaceutical domain marks robust domestic distribution and active export across global markets. Sale price and list price are competitively set to ensure affordability without sacrificing quality, supporting both distributors and traders. Payment terms are flexible for seamless transactions whether for bulk purchase or individual supply. Registered status confirms regulatory compliance, while selective availability underscores its prescription-only use for authorized medical professionals.

FAQ's of 60 Mg Cabazitaxel Injection:

Q: How is 60 Mg Cabazitaxel Injection administered?

A: 60 Mg Cabazitaxel Injection is administered via intravenous infusion only, after proper dilution and reconstitution under strict medical supervision.

Q: What are the main indications for using Cabazitaxel Injection?

A: This injection is primarily indicated for the treatment of metastatic castration-resistant prostate cancer in patients who have previously received other chemotherapy agents.

Q: When should precautions be taken with this product?

A: Precautions must be observed in patients with renal or hepatic impairment, and it is contraindicated in individuals with known hypersensitivity or neutropenia.

Q: Where is the injection manufactured and distributed from?

A: The injection is sourced from certified pharmaceutical manufacturers in India and distributed for both domestic and export markets.

Q: What is the process for preparing the injection for use?

A: The injection must be diluted before administration. Healthcare professionals should follow the manufacturer's protocol for safe reconstitution and infusion.

Q: What benefits does the sterile glass vial feature offer?

A: The sterile, single-use glass vial with rubber stopper and aluminum seal maintains product integrity, ensuring safety, and reducing contamination risk during handling and administration.

Tell us about your requirement